Knight Therapeutics Inc
F:04K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Knight Therapeutics Inc
F:04K
|
CA |
|
Kenon Holdings Ltd
F:76N
|
SG |
|
Wawel SA
F:0K6
|
PL |
|
Big River Industries Ltd
F:BQ3
|
AU |
|
V
|
Very Good Tour Co Ltd
KOSDAQ:094850
|
KR |
|
SmartStop Self Storage REIT Inc
NYSE:SMA
|
US |
|
D
|
Donnelley Financial Solutions Inc
F:1DN
|
US |
|
Energia Innovacion y Desarrollo Fotovoltaico SA
F:F63
|
ES |
|
E
|
Ebest Special Purpose Acquisition No6 Company
KOSDAQ:478110
|
KR |
|
M
|
Meritz No.1 Special Purpose Acquisition Co
KOSDAQ:0088D0
|
KR |
|
H
|
HALO Technologies Holdings Ltd
ASX:HAL
|
AU |
|
Angel Seafood Holdings Ltd
F:ALM1
|
AU |
Bankruptcy Probability
Knight Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Knight Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
K
|
Knight Therapeutics Inc
TSX:GUD
|
1.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Knight Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Knight Therapeutics Inc has total debt of 14.6m CAD. This includes both short-term (0 CAD) and long-term (14.6m CAD) debt.
You can find a full breakdown on its Balance Sheet.